Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: Q4Q5Y9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.477 |
CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.504 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.625 |
CLV_PCSK_PC1ET2_1 | 92 | 94 | PF00082 | 0.645 |
DOC_CDC14_PxL_1 | 11 | 19 | PF14671 | 0.419 |
DOC_MAPK_gen_1 | 77 | 85 | PF00069 | 0.394 |
DOC_MAPK_gen_1 | 92 | 102 | PF00069 | 0.349 |
DOC_MAPK_MEF2A_6 | 79 | 87 | PF00069 | 0.391 |
DOC_MAPK_MEF2A_6 | 95 | 104 | PF00069 | 0.423 |
DOC_MAPK_RevD_3 | 100 | 115 | PF00069 | 0.362 |
DOC_USP7_UBL2_3 | 73 | 77 | PF12436 | 0.451 |
LIG_14-3-3_CanoR_1 | 28 | 37 | PF00244 | 0.649 |
LIG_14-3-3_CanoR_1 | 79 | 87 | PF00244 | 0.463 |
LIG_BRCT_BRCA1_1 | 59 | 63 | PF00533 | 0.447 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.452 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.416 |
LIG_FHA_1 | 36 | 42 | PF00498 | 0.636 |
LIG_LIR_Gen_1 | 3 | 12 | PF02991 | 0.474 |
LIG_LIR_Gen_1 | 59 | 68 | PF02991 | 0.356 |
LIG_LIR_Nem_3 | 18 | 23 | PF02991 | 0.314 |
LIG_LIR_Nem_3 | 3 | 7 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 59 | 64 | PF02991 | 0.321 |
LIG_PCNA_PIPBox_1 | 13 | 22 | PF02747 | 0.402 |
LIG_Pex14_1 | 70 | 74 | PF04695 | 0.366 |
LIG_Pex14_2 | 61 | 65 | PF04695 | 0.384 |
LIG_SH2_CRK | 23 | 27 | PF00017 | 0.480 |
LIG_SH2_PTP2 | 101 | 104 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 101 | 104 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 23 | 26 | PF00017 | 0.438 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.447 |
LIG_TRAF2_1 | 121 | 124 | PF00917 | 0.630 |
LIG_UBA3_1 | 64 | 73 | PF00899 | 0.544 |
LIG_WRC_WIRS_1 | 1 | 6 | PF05994 | 0.507 |
LIG_WRC_WIRS_1 | 58 | 63 | PF05994 | 0.381 |
MOD_CK1_1 | 134 | 140 | PF00069 | 0.644 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.374 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.435 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.555 |
MOD_GlcNHglycan | 128 | 132 | PF01048 | 0.520 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.481 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.404 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.456 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.368 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.668 |
MOD_N-GLC_1 | 44 | 49 | PF02516 | 0.247 |
MOD_NEK2_2 | 15 | 20 | PF00069 | 0.480 |
MOD_PKA_1 | 114 | 120 | PF00069 | 0.246 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.728 |
MOD_PKA_2 | 35 | 41 | PF00069 | 0.627 |
MOD_PKA_2 | 78 | 84 | PF00069 | 0.466 |
MOD_Plk_1 | 81 | 87 | PF00069 | 0.388 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.426 |
MOD_Plk_4 | 47 | 53 | PF00069 | 0.334 |
MOD_SUMO_rev_2 | 84 | 94 | PF00179 | 0.443 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.447 |
TRG_ER_diArg_1 | 125 | 127 | PF00400 | 0.711 |
TRG_ER_diArg_1 | 93 | 96 | PF00400 | 0.416 |
TRG_NLS_MonoExtC_3 | 91 | 97 | PF00514 | 0.355 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4A6 | Leptomonas seymouri | 67% | 99% |
A0A0S4IVS1 | Bodo saltans | 24% | 90% |
A0A1X0NIN7 | Trypanosomatidae | 37% | 100% |
A0A3R7L4C4 | Trypanosoma rangeli | 35% | 87% |
A0A3S7X4X5 | Leishmania donovani | 95% | 100% |
A4HJQ9 | Leishmania braziliensis | 78% | 100% |
A4I776 | Leishmania infantum | 95% | 100% |
C9ZMF7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9B270 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |